Your session is about to expire
← Back to Search
Apomorphine Sublingual Film for Restless Legs Syndrome
Study Summary
This trial is testing a new drug for restless legs syndrome, to see if it improves symptoms beyond what current treatments can do.
- Restless Legs Syndrome
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2017 Phase 3 trial • 107 Patients • NCT02006121Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Who meets the criteria to be included in this research?
"For this research study, 16 participants with restless leg syndrome between the age of 21 and 80 are necessary. Idiopathic RLS must be diagnosed in accordance to standard criteria as well as an IRLS score higher than 15 while taking 1+ medications for their condition. Additionally, medication stability over a 2-week period is required prior to enrollment."
Is the recruitment process still open for this research endeavor?
"Reports from clinicaltrials.gov confirm that this specific medical trial is not presently seeking volunteers, notwithstanding the original posting date of September 1st 2022 and its recent update on the same day. Nevertheless, 1425 other trials are currently recruiting participants for their studies."
Is Apomorphine Sublingual Film a safe option for patients with regards to side effects?
"Apomorphine Sublingual Film has been approved, so it was awarded a score of 3."
Are there elderly participants in your research endeavor?
"The requirements for enrolment in this clinical trial necessitate that candidates are aged 21 to 80. For those below the age of majority, there exist 384 other studies while 1,011 trials welcome seniors past 65."
Share this study with friends
Copy Link
Messenger